NFE2L2 and gastric cancer: Other compounds such as apigenin, omipalisib, and entinostat have been used to block the NRF2 mRNA translation by direct or indirect mechanisms, promoting anticancer effects in experimental models of hepatic cancer [106], gastric cancer [107], as well as sarcoma and osteosarcoma [108], respectively.